Overview The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia Status: Unknown status Trial end date: 2018-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety and efficacy of PEG-rhG-CSF in preventing chemotherapy-induced neutropenia Phase: Phase 3 Details Lead Sponsor: wang shusen